Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome.
Alexander KolevzonMichael S BreenPaige M SiperDanielle HalpernYitzchak FrankH RiegerJ WeismannMaria Del Pilar TrellesBonnie LermanRobert RapaportJoseph D BuxbaumPublished in: Molecular autism (2022)
IGF-1 is efficacious in improving sensory reactivity symptoms, repetitive behaviors, and hyperactivity in children with PMS. Trial registration NCT01525901.